Clinical Trial Update: Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ipilimumab plus paclitaxel and carboplatin versus placebo in squamous non-small cell lung cancer; study completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lung Cancer - Non Small Cell Squamous | Phase 3 | Status: COMPLETED | Results posted: 2016-06-23